S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
International Paper's 5% Yield Offers Big Value
Warren Buffett's company dumps another 5 million shares of printer maker HP
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
How You Can Beat the Yields on near 5% Treasuries, plus Upside
This Is One of the Top-Rated and Most-Upgraded Stocks
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
5 Economic Trends That Will Drive The Market In Q4
Stock market today: World shares are mostly lower, tracking a rates-driven tumble on Wall Street
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
International Paper's 5% Yield Offers Big Value
Warren Buffett's company dumps another 5 million shares of printer maker HP
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
How You Can Beat the Yields on near 5% Treasuries, plus Upside
This Is One of the Top-Rated and Most-Upgraded Stocks
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
5 Economic Trends That Will Drive The Market In Q4
Stock market today: World shares are mostly lower, tracking a rates-driven tumble on Wall Street
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
International Paper's 5% Yield Offers Big Value
Warren Buffett's company dumps another 5 million shares of printer maker HP
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
How You Can Beat the Yields on near 5% Treasuries, plus Upside
This Is One of the Top-Rated and Most-Upgraded Stocks
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
5 Economic Trends That Will Drive The Market In Q4
Stock market today: World shares are mostly lower, tracking a rates-driven tumble on Wall Street
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
International Paper's 5% Yield Offers Big Value
Warren Buffett's company dumps another 5 million shares of printer maker HP
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
How You Can Beat the Yields on near 5% Treasuries, plus Upside
This Is One of the Top-Rated and Most-Upgraded Stocks
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
5 Economic Trends That Will Drive The Market In Q4
Stock market today: World shares are mostly lower, tracking a rates-driven tumble on Wall Street
NASDAQ:IRIX

IRIDEX (IRIX) Stock Forecast, Price & News

$2.74
+0.11 (+4.18%)
(As of 10/3/2023 ET)
Compare
Today's Range
$2.60
▼
$2.89
50-Day Range
$1.33
▼
$2.74
52-Week Range
$1.31
▼
$2.88
Volume
288,807 shs
Average Volume
98,904 shs
Market Capitalization
$44.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

IRIDEX MarketRank™ Forecast

Analyst Rating
0.00 Rating Score
Upside/​Downside
27.0% Downside
$2.00 Price Target
Short Interest
Healthy
0.78% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.30mentions of IRIDEX in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.48) to ($0.30) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.74 out of 5 stars

Computer And Technology Sector

595th out of 597 stocks

Electromedical Equipment Industry

20th out of 20 stocks

See Top Rated MarketRank™ Stocks Here

IRIX stock logo

About IRIDEX (NASDAQ:IRIX) Stock

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

IRIX Price History

IRIX Stock News Headlines

September 29, 2023 | americanbankingnews.com
IRIDEX (NASDAQ:IRIX) Earns Buy Rating from Analysts at StockNews.com
August 30, 2023 | finanznachrichten.de
IRIDEX Corporation: Iridex Announces Strategic Review to Unlock Shareholder Value
October 4, 2023 | Vector Vest (Ad)
Master the Market: Is That Stock Worth The Buy? Free Stock Report
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
August 29, 2023 | seekingalpha.com
Iridex announces review of strategic alternatives, stock rises
August 29, 2023 | finance.yahoo.com
Iridex Announces Strategic Review to Unlock Shareholder Value
August 11, 2023 | markets.businessinsider.com
Iridex Reports Second Quarter 2023 Financial Results
August 9, 2023 | markets.businessinsider.com
IRIDEX earnings preview: what Wall Street is expecting
August 9, 2023 | finance.yahoo.com
We Think IRIDEX (NASDAQ:IRIX) Needs To Drive Business Growth Carefully
October 4, 2023 | Vector Vest (Ad)
Master the Market: Is That Stock Worth The Buy? Free Stock Report
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
July 28, 2023 | finance.yahoo.com
Iridex to Report Second Quarter Financial Results on August 10, 2023
June 21, 2023 | finance.yahoo.com
Zacks Industry Outlook Highlights IPG Photonics and IRIDEX
June 8, 2023 | finance.yahoo.com
IRIDEX Corporation's (NASDAQ:IRIX) Price Is Right But Growth Is Lacking
May 18, 2023 | finance.yahoo.com
Iridex (IRIX) Is Attractively Priced Despite Fast-paced Momentum
May 11, 2023 | msn.com
Iridex: Q1 Earnings Insights
May 11, 2023 | finance.yahoo.com
Iridex Reports First Quarter 2023 Financial Results
April 27, 2023 | finance.yahoo.com
Iridex to Report First Quarter Financial Results on May 11, 2023
April 12, 2023 | finance.yahoo.com
Multiple insiders bought IRIDEX Corporation (NASDAQ:IRIX) stock earlier this year, a positive sign for shareholders
March 13, 2023 | finance.yahoo.com
IRIDEX Corporation (NASDAQ:IRIX) Q4 2022 Earnings Call Transcript
March 9, 2023 | finance.yahoo.com
Iridex Reports Fourth Quarter and Full Year 2022 Financial Results
March 7, 2023 | finance.yahoo.com
Iridex to Present at the 35th Annual Roth Conference
March 2, 2023 | finance.yahoo.com
We're Keeping An Eye On IRIDEX's (NASDAQ:IRIX) Cash Burn Rate
March 2, 2023 | finance.yahoo.com
Iridex Introduces New Research and Showcases Five Events at the AGS Meeting
February 23, 2023 | finance.yahoo.com
Iridex to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
January 10, 2023 | finance.yahoo.com
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2022
December 6, 2022 | finance.yahoo.com
Iridex to Participate in Fireside Chat with Stifel Equity Research
November 13, 2022 | finance.yahoo.com
IRIDEX Third Quarter 2022 Earnings: Beats Expectations
November 10, 2022 | finance.yahoo.com
Iridex Announces Record Third Quarter 2022 Financial Results
See More Headlines
Receive IRIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRIDEX and its competitors with MarketBeat's FREE daily newsletter.

IRIX Company Calendar

Last Earnings
8/10/2023
Today
10/04/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Computer and Technology
Current Symbol
NASDAQ:IRIX
CUSIP
N/A
CIK
1006045
Web
www.iridex.com
Phone
(650) 940-4700
Fax
650-940-4710
Employees
130
Year Founded
1989

Price Target and Rating

Average Stock Price Forecast
$2.00
High Stock Price Forecast
$2.00
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
-27.0%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.48)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-7,550,000.00
Net Margins
-13.78%
Pretax Margin
-13.69%
Return on Equity
-48.09%
Return on Assets
-18.82%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.53
Quick Ratio
1.62

Sales & Book Value

Annual Sales
$56.97 million
Price / Sales
0.78
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.08 per share
Price / Book
2.54

Miscellaneous

Outstanding Shares
16,230,000
Free Float
15,223,000
Market Cap
$44.47 million
Optionable
Not Optionable
Beta
0.99

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover
Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. David I. Bruce (Age 64)
    Pres, CEO & Director
    Comp: $459.31k
  • Mr. Patrick Mercer (Age 51)
    Chief Operating Officer
    Comp: $385.51k
  • Ms. Leigh Salvo
    Head of Investor Relations

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













IRIX Stock - Frequently Asked Questions

What is IRIDEX's stock price forecast for 2023?

0 brokers have issued 1 year price targets for IRIDEX's stock. Their IRIX share price forecasts range from $2.00 to $2.00. On average, they expect the company's stock price to reach $2.00 in the next twelve months. This suggests that the stock has a possible downside of 27.0%.
View analysts price targets for IRIX or view top-rated stocks among Wall Street analysts.

How have IRIX shares performed in 2023?

IRIDEX's stock was trading at $2.01 on January 1st, 2023. Since then, IRIX stock has increased by 36.3% and is now trading at $2.74.
View the best growth stocks for 2023 here.

Are investors shorting IRIDEX?

IRIDEX saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 93,600 shares, an increase of 52.9% from the August 31st total of 61,200 shares. Based on an average daily volume of 41,600 shares, the days-to-cover ratio is presently 2.3 days. Approximately 0.8% of the company's shares are short sold.
View IRIDEX's Short Interest.

When is IRIDEX's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our IRIX earnings forecast.

How were IRIDEX's earnings last quarter?

IRIDEX Co. (NASDAQ:IRIX) posted its quarterly earnings data on Thursday, August, 10th. The medical equipment provider reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.11) by $0.06. The medical equipment provider had revenue of $12.86 million for the quarter, compared to analyst estimates of $14.23 million. IRIDEX had a negative net margin of 13.78% and a negative trailing twelve-month return on equity of 48.09%.

What guidance has IRIDEX issued on next quarter's earnings?

IRIDEX updated its FY 2023 earnings guidance on Thursday, August, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $55.00 million-$57.00 million, compared to the consensus revenue estimate of $58.05 million.

What is Theodore A. Boutacoff's approval rating as IRIDEX's CEO?

7 employees have rated IRIDEX Chief Executive Officer Theodore A. Boutacoff on Glassdoor.com. Theodore A. Boutacoff has an approval rating of 64% among the company's employees.

What other stocks do shareholders of IRIDEX own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IRIDEX investors own include NVIDIA (NVDA), Trevena (TRVN), CTI BioPharma (CTIC), Agile Therapeutics (AGRX), Genocea Biosciences (GNCA), Idera Pharmaceuticals (IDRA), Lipocine (LPCN), Rigel Pharmaceuticals (RIGL) and SCYNEXIS (SCYX).

What is IRIDEX's stock symbol?

IRIDEX trades on the NASDAQ under the ticker symbol "IRIX."

How do I buy shares of IRIDEX?

Shares of IRIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IRIDEX's stock price today?

One share of IRIX stock can currently be purchased for approximately $2.74.

How much money does IRIDEX make?

IRIDEX (NASDAQ:IRIX) has a market capitalization of $44.47 million and generates $56.97 million in revenue each year. The medical equipment provider earns $-7,550,000.00 in net income (profit) each year or ($0.48) on an earnings per share basis.

How many employees does IRIDEX have?

The company employs 130 workers across the globe.

How can I contact IRIDEX?

IRIDEX's mailing address is 1212 Terra Bella Avenue, Mountain View CA, 94043. The official website for the company is www.iridex.com. The medical equipment provider can be reached via phone at (650) 940-4700, via email at investors@iridex.com, or via fax at 650-940-4710.

This page (NASDAQ:IRIX) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -